Chengdu Kanghua Stock Hits Day Low Amid Price Pressure, Closing at CNY 61.71

Chengdu Kanghua Biological Products Co., Ltd. experienced a significant decline in its stock performance today, with a drop of 5.37%. The stock reached an intraday low of CNY 61.71, reflecting ongoing challenges within the company. Over the past week, the stock has decreased by 10.46%, and its performance over the last month shows a decline of 11.5%. In terms of longer-term performance, Chengdu Kanghua has faced notable difficulties, with a year-to-date decline of 14.23% and a staggering 70.21% drop over the past five years. Despite a positive return of 14.86% over the past year, the company has reported a significant decrease in net profit, falling by 86.17% in its most recent quarterly results. Financial metrics indicate a return on equity of 6.61% and a price-to-book ratio of 1.86, suggesting a fair valuation in the current market. The company operates within the pharmaceuticals and biotechnology sector, holding a market capitalization of CNY 6,536 million.